md-medicaldata

Authors

 

Dimitrije Stevanović ^1,2, Tanja Lakić<sup>1,2

1</sup>Univerzitetski klinički centar Vojvodine, Centar za patologiju i histologiju, Novi Sad, Srbija
²Medicinski fakultet, Univerzitet u Novom Sadu, Novi Sad, Srbija

 

UDK: 616-006.44-074
616.419-076

The paper was received / Rad primljen: 21.12.2022.

Accepted / Rad prihvaćen: 21.02.2022.

 

Correspondence to:

Dimitrije Stevanović
Fruškogorskog odreda 8,
21132 Petrovaradin, Srbija
+381631658788
e-mail: nsdimitrije@gmail.com

 

 

Sažetak

 

Uvod: Razvoj novih metoda dijagnostike limfoma, u nekim zemljama polako potiskuje potrebu za biopsijom koštane srži, te je neophodno kontinuirano unapređivanje znanja o dijagnostičkim metodama, ne bi li se značaj istih potvrdio ili opovrgao. Materijal i metode: Retrospektivno je izvršena analiza patohistoloških izveštaja bolesnika kojima je tokom 2019. i 2020. godine u Centru za patologiju i histologiju Univerzitetskog kliničkog centra Vojvodine u Novom Sadu patohistološki verifikovana infiltracija koštane srži primarnim limfomom. Rezultati: Ukupno je registrovano 75 ispitanika, prosečne starosti 58 godina, pri čemu su 44% činili muškarci, a 56% žene. Izuzimajući HLL/SLL, najčešći limfomi su bili „mantle cell“ i limfomi marginalne zone. „Mantle cell“ limfom je bio češći kod muškaraca, dok su u ženskoj populaciji frekventniji bili difuzni krupnoćelijski, sitnoćelijski limfocitni i limfom marginalne zone. Prosečna celularnost koštane srži iznosila je 61,47%, dok je prosečna zahvaćenost koštane srži atipičnim limfoidnim infiltratom iznosila 37%. Zaključak: Koštana srž zahvaćena limfomima je u većini slučajeva hipercelularna ili normalne celularnosti u odnosu na starost ispitanika, prosečne infiltracije 37%, retikularne osnove gradusa II, sa različitom polnom predominacijom u zavisnosti od patohistološkog tipa.

 

 

 

Ključne reči:

limfomi; infiltracija; biopsija

 

 

 

Abstract

Introduction: In some countries, development of new diagnostic methods for the lymphoma diagnosis is slowly suppressing the need for bone marrow biopsy and it is necessary to continuously improve knowledge about diagnostic methods, in order to confirm or refute the importance of them. Materials and methods: Retrospectively, we analyzed bone marrow biopsy reports from patients who had infiltration of bone marrow by lymphoma during years 2019-2020. All cases were diagnosed in the Center for pathology and histology of the University Clinical Center of Vojvodina, in Novi Sad. Results: Diagnosis was pathohistologically verified in 75 cases, with female predominance - 44% were males and 56% were females with average age of 58 years. Except CLL/SLL, most common lymphomas involving bone marrow were „mantle cell“ and marginal zone lymphomas. „Mantle cell“ lymphomas were more common in males, whereas small lymphocytic, diffuse large B-cell and marginal zone lymphomas affected female patients more. Average bone marrow cellularity was 61.47% and percentage of tumor infiltration averaged at 37%. Conclusion: According to age, bone marrow involved by lymphomas was in most cases hypercellular or normocellular, with average infiltration of 37%, grade II reticular fibrosis and different gender disparity depending on pathohistologycal lymphoma type.

 

 

Keywords:

lymphoma; infiltration; biopsy

 

 

 

 

References:

1. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 8th Ed. Philadelphia: Saunders/Elsevier; 2009. p.596-620.
2. Cancerresearchuk.org [homepage on the Internet]. London: Cancer Research UK; 2017. [cited 2021. July 25]. Available from: https://www.cancerresearchuk.org.
3. Lymphoma-action.org.uk [homepage on the Internet]. Aylesbury: Lymphoma action; 2018. [cited 2021. January 18]. Available from: https://www.lymphoma-action.org.uk.
4. Jovanović V. Maligni tumori u Republici Srbiji 2018. [Internet]. Beograd: Institut za javno zdravlje Srbije “Dr Milan Jovanović Batut”, Odeljenje za prevenciju i kontrolu nezaraznih bolesti; 2020. [cited 2021. January 18]. p.46-57. Report No: ISBN 978-86-7358-111-8
5. Gco.iarc.fr [homepage on the Internet]. Lyon: International Agency for Research on Cancer. 2020. [cited 2021. January 3]. Available from: https://www.gco.iarc.fr/.
6. Pathologyoutlines.com [homepage on the Internet]. Bingham Farms: Pathology Outlines [cited 2022. Jan 01]. Available from: https://www.pathologyoutlines.com.
7. Cancercenter.com [homepage on the Internet]. Tulsa: Cancer Treament Centers of America 2020 [updated 2020 November 05; cited 2021 January 28]. Available from https://www.cancercenter.com.
8. Chen-Liang TH, Martin-Santos T, Jerez A, Senent L, Orero MT, Remigia MJ et al. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients [published correction appears in Am J Hematol. 2016 May;91(5):E300]. Am J Hematol. 2015;90(8):686-690. DOI: 10.1002/ajh.24044
9. Çetin G, Çıkrıkçıoğlu MA, Özkan T, Karatoprak C, Cem Ar M, Emre Eşkazan A et al. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?. Turk J Haematol. 2015;32(3):213-219. DOI: 10.4274/tjh.2013.0336.
10. Merli M, Arcaini L, Boveri E, Rattotti S, Picone C, Passamonti F et al. Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. Eur J Haematol. 2010;85(5):405-415. DOI:10.1111/j.1600-0609.2010.01503.x
11. Adams HJ, Nievelstein RA, Kwee TC. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev. 2015;29(6):417-425. DOI:10.1016/j.blre.2015.06.003
12. Kwoun WJ, Ahn JY, Park PW, Seo YH, Kim KH, Seo JY et al. How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution. J Clin Lab Anal. 2019;33(4):e22841. DOI:10.1002/jcla.22841
13. Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C et al. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases. Turk J Haematol. 2020;37(4):220-225. DOI:10.4274/tjh.galenos.2020.2019.0361
14. Sriskandarajah P, Dearden CE. Epidemiology and environmental aspects of marginal zone lymphomas. Best Pract Res Clin Haematol. 2017;30(1-2):84-91. DOI:10.1016/j.beha.2016.07.002
15. Shi YF, Li XH, Song YQ, Song WW, Lai YM. Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China. Int J Clin Exp Pathol. 2015;8(6):7102-7111. Published 2015 Jun 1.
16. Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005; 29(12):1549-57. DOI:10.1097/01.pas.0000182405.65041.8b
17. Lee WI, Lee JH, Kim IS, Lee KN, Kim SH. Bone marrow involvement by non-Hodgkin's lymphom. J Korean Med Sci. 1994;9(5):402-8. DOI:10.3346/jkms.1994.9.5.402
18. Sovani V, Harvey C, Haynes AP, McMillan AK, Clark DM, O'Connor SR. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings. J Clin Pathol. 2014;67(5):389-95. DOI:10.1136/jclinpath-2013-201520
19. Zahur U, Zafar L, Khaliq S, Rehan M, Khalid A. Frequency And Pattern Of Bone Marrow Involvement Among Patients With Non Hodgkin Lymphoma. J Ayub Med Coll Abbottabad. 2016;28(3):497-500.
    

PDFStevanović D. et al MD-Medical Data 2022;14(1-2) 013-017